Concepts (73)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Neoplasms | 2 | 2023 | 126 | 1.020 |
Why?
|
| Lipoma | 1 | 2025 | 18 | 0.890 |
Why?
|
| Ankle | 1 | 2025 | 28 | 0.880 |
Why?
|
| Giant Cell Tumor of Bone | 1 | 2023 | 8 | 0.810 |
Why?
|
| Bone Cysts, Aneurysmal | 1 | 2020 | 9 | 0.640 |
Why?
|
| Bone Plates | 1 | 2020 | 38 | 0.630 |
Why?
|
| Fracture Fixation, Internal | 1 | 2020 | 65 | 0.610 |
Why?
|
| Hip Fractures | 1 | 2020 | 77 | 0.590 |
Why?
|
| Neuromuscular Diseases | 1 | 2018 | 22 | 0.550 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 695 | 0.500 |
Why?
|
| Eosinophilic Granuloma | 1 | 2015 | 3 | 0.480 |
Why?
|
| Diagnosis, Differential | 5 | 2025 | 984 | 0.470 |
Why?
|
| Knee | 1 | 2015 | 40 | 0.470 |
Why?
|
| Adamantinoma | 1 | 2010 | 1 | 0.330 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 2010 | 5 | 0.330 |
Why?
|
| Neoplasms | 1 | 2018 | 1392 | 0.260 |
Why?
|
| Metacarpophalangeal Joint | 1 | 2005 | 10 | 0.220 |
Why?
|
| Joint Dislocations | 1 | 2005 | 18 | 0.220 |
Why?
|
| Mesenchymoma | 1 | 2023 | 3 | 0.210 |
Why?
|
| Osteomalacia | 1 | 2023 | 5 | 0.210 |
Why?
|
| Neoplasms, Connective Tissue | 1 | 2023 | 4 | 0.210 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2023 | 10 | 0.210 |
Why?
|
| Radius | 1 | 2023 | 16 | 0.200 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2023 | 32 | 0.200 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2023 | 9 | 0.200 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2023 | 20 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2025 | 2218 | 0.190 |
Why?
|
| Male | 6 | 2025 | 30323 | 0.180 |
Why?
|
| Humans | 12 | 2025 | 64279 | 0.170 |
Why?
|
| Female | 6 | 2025 | 33382 | 0.130 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2015 | 16 | 0.120 |
Why?
|
| Image-Guided Biopsy | 1 | 2015 | 50 | 0.120 |
Why?
|
| Orthopedic Procedures | 1 | 2015 | 53 | 0.110 |
Why?
|
| Vanadium Compounds | 1 | 2013 | 4 | 0.100 |
Why?
|
| Disease Progression | 1 | 2018 | 1176 | 0.100 |
Why?
|
| Ultrasonography | 1 | 2015 | 486 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 666 | 0.100 |
Why?
|
| Adult | 4 | 2023 | 17133 | 0.090 |
Why?
|
| Middle Aged | 4 | 2018 | 17923 | 0.090 |
Why?
|
| Hypoglycemic Agents | 1 | 2013 | 221 | 0.090 |
Why?
|
| Glomus Tumor | 1 | 2010 | 2 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2482 | 0.080 |
Why?
|
| Leg | 1 | 2010 | 87 | 0.080 |
Why?
|
| Spinal Injuries | 1 | 2009 | 12 | 0.080 |
Why?
|
| Thoracic Vertebrae | 1 | 2009 | 35 | 0.080 |
Why?
|
| Adolescent | 1 | 2020 | 6305 | 0.070 |
Why?
|
| Spondylolisthesis | 1 | 2009 | 45 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2018 | 5697 | 0.070 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 529 | 0.070 |
Why?
|
| Young Adult | 1 | 2018 | 4781 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 1669 | 0.070 |
Why?
|
| Spinal Fusion | 1 | 2009 | 152 | 0.070 |
Why?
|
| Radiography | 2 | 2009 | 553 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 709 | 0.060 |
Why?
|
| Prognosis | 1 | 2010 | 1769 | 0.060 |
Why?
|
| Splints | 1 | 2005 | 6 | 0.060 |
Why?
|
| Aged | 2 | 2018 | 14664 | 0.050 |
Why?
|
| Reoperation | 1 | 2023 | 292 | 0.050 |
Why?
|
| Biopsy | 1 | 2023 | 449 | 0.040 |
Why?
|
| Globulins | 1 | 2013 | 2 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2013 | 498 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2013 | 374 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2013 | 487 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2010 | 27 | 0.020 |
Why?
|
| Internal Fixators | 1 | 2009 | 11 | 0.020 |
Why?
|
| Bone Screws | 1 | 2009 | 35 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 156 | 0.020 |
Why?
|
| Gadolinium | 1 | 2010 | 110 | 0.020 |
Why?
|
| Device Removal | 1 | 2009 | 65 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2009 | 122 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2010 | 288 | 0.020 |
Why?
|
| Contrast Media | 1 | 2010 | 429 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 800 | 0.010 |
Why?
|